Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 162 entries
Sorted by: Best Match Show Resources per page
Statement of retraction.

Immunological investigations

[No authors listed]
PMID: 19860595
Immunol Invest. 2009;38(8):869. doi: 10.3109/08820130903336333.

No abstract available.

Cite
Statement of retraction. Immunol Invest. 2009;38(8):869doi: 10.3109/08820130903336333.
(2009). Statement of retraction. Immunological investigations, 38(8), 869. https://doi.org/10.3109/08820130903336333
"Statement of retraction." Immunological investigations vol. 38,8 (2009): 869. doi: https://doi.org/10.3109/08820130903336333
Statement of retraction. Immunol Invest. 2009;38(8):869. doi: 10.3109/08820130903336333. PMID: 19860595.
Copy Download .nbib Format: NLM
Association of Polymorphisms in Cytokine genes with susceptibility to Precancerous Lesions and Cervical Cancer: A systematic review with meta-analysis.

Immunological investigations

de Moura EL, Dos Santos ACM, da Silva DM, Dos Santos BB, Figueredo DS, Moura AWA, da Silva AF, Tanabe ISB, de Lira Tanabe EL, Lira Neto AB, Pereira E Silva AC, de Carvalho Fraga CA, de Lima Filho JL, de Farias KF, Martins de Souza EV.
PMID: 32602796
Immunol Invest. 2021 Jul;50(5):492-526. doi: 10.1080/08820139.2020.1778023. Epub 2020 Jun 30.

No abstract available.

Cite
de Moura EL, Dos Santos ACM, da Silva DM, et al. Association of Polymorphisms in Cytokine genes with susceptibility to Precancerous Lesions and Cervical Cancer: A systematic review with meta-analysis. Immunol Invest. 2020;50(5):492-526doi: 10.1080/08820139.2020.1778023.
de Moura, E. L., Dos Santos, A. C. M., da Silva, D. M., Dos Santos, B. B., Figueredo, D. S., Moura, A. W. A., da Silva, A. F., Tanabe, I. S. B., de Lira Tanabe, E. L., Lira Neto, A. B., Pereira E Silva, A. C., de Carvalho Fraga, C. A., de Lima Filho, J. L., de Farias, K. F., & Martins de Souza, E. V. (2021). Association of Polymorphisms in Cytokine genes with susceptibility to Precancerous Lesions and Cervical Cancer: A systematic review with meta-analysis. Immunological investigations, 50(5), 492-526. https://doi.org/10.1080/08820139.2020.1778023
de Moura, Edilson Leite, et al. "Association of Polymorphisms in Cytokine genes with susceptibility to Precancerous Lesions and Cervical Cancer: A systematic review with meta-analysis." Immunological investigations vol. 50,5 (2021): 492-526. doi: https://doi.org/10.1080/08820139.2020.1778023
de Moura EL, Dos Santos ACM, da Silva DM, Dos Santos BB, Figueredo DS, Moura AWA, da Silva AF, Tanabe ISB, de Lira Tanabe EL, Lira Neto AB, Pereira E Silva AC, de Carvalho Fraga CA, de Lima Filho JL, de Farias KF, Martins de Souza EV. Association of Polymorphisms in Cytokine genes with susceptibility to Precancerous Lesions and Cervical Cancer: A systematic review with meta-analysis. Immunol Invest. 2021 Jul;50(5):492-526. doi: 10.1080/08820139.2020.1778023. Epub 2020 Jun 30. PMID: 32602796.
Copy Download .nbib Format: NLM
Transcriptomic Profiling of Circulating HLA-DR.

Immunological investigations

Saleh R, Taha RZ, Sasidharan Nair V, Toor SM, Alajez NM, Elkord E.
PMID: 32727251
Immunol Invest. 2021 Nov;50(8):952-963. doi: 10.1080/08820139.2020.1795875. Epub 2020 Jul 29.

Myeloid-derived suppressor cells (MDSCs) are a heterogeneous population of cells with potent immunosuppressive functions, which can inhibit the activation of immune responses under a steady-state condition and pathological conditions. We performed transcriptomic profiling of circulating CD33

Cite
Saleh R, Taha RZ, Sasidharan Nair V, et al. Transcriptomic Profiling of Circulating HLA-DR. Immunol Invest. 2020;50(8):952-963doi: 10.1080/08820139.2020.1795875.
Saleh, R., Taha, R. Z., Sasidharan Nair, V., Toor, S. M., Alajez, N. M., & Elkord, E. (2021). Transcriptomic Profiling of Circulating HLA-DR. Immunological investigations, 50(8), 952-963. https://doi.org/10.1080/08820139.2020.1795875
Saleh, Reem, et al. "Transcriptomic Profiling of Circulating HLA-DR." Immunological investigations vol. 50,8 (2021): 952-963. doi: https://doi.org/10.1080/08820139.2020.1795875
Saleh R, Taha RZ, Sasidharan Nair V, Toor SM, Alajez NM, Elkord E. Transcriptomic Profiling of Circulating HLA-DR. Immunol Invest. 2021 Nov;50(8):952-963. doi: 10.1080/08820139.2020.1795875. Epub 2020 Jul 29. PMID: 32727251.
Copy Download .nbib Format: NLM
Effects of Complement Regulators and Chemokine Receptors in Type 2 Diabetes.

Immunological investigations

Aydin Ozgur B, Coskunpinar E, Bilgic Gazioglu S, Yilmaz A, Musteri Oltulu Y, Cakmakoglu B, Deniz G, Gurol AO, Yilmaz MT.
PMID: 32611246
Immunol Invest. 2021 Jul;50(5):478-491. doi: 10.1080/08820139.2020.1778022. Epub 2020 Jul 02.

CD55 and CD59 are complement regulatory proteins suggested to be related with progression of diabetes and its complications. The stromal cell-derived factor 1 (SDF-1) and C-X-C chemokine receptor type 4 (CXCR-4) are chemokine proteins. We aimed to investigate the...

Cite
Aydin Ozgur B, Coskunpinar E, Bilgic Gazioglu S, et al. Effects of Complement Regulators and Chemokine Receptors in Type 2 Diabetes. Immunol Invest. 2020;50(5):478-491doi: 10.1080/08820139.2020.1778022.
Aydin Ozgur, B., Coskunpinar, E., Bilgic Gazioglu, S., Yilmaz, A., Musteri Oltulu, Y., Cakmakoglu, B., Deniz, G., Gurol, A. O., & Yilmaz, M. T. (2021). Effects of Complement Regulators and Chemokine Receptors in Type 2 Diabetes. Immunological investigations, 50(5), 478-491. https://doi.org/10.1080/08820139.2020.1778022
Aydin Ozgur, B, et al. "Effects of Complement Regulators and Chemokine Receptors in Type 2 Diabetes." Immunological investigations vol. 50,5 (2021): 478-491. doi: https://doi.org/10.1080/08820139.2020.1778022
Aydin Ozgur B, Coskunpinar E, Bilgic Gazioglu S, Yilmaz A, Musteri Oltulu Y, Cakmakoglu B, Deniz G, Gurol AO, Yilmaz MT. Effects of Complement Regulators and Chemokine Receptors in Type 2 Diabetes. Immunol Invest. 2021 Jul;50(5):478-491. doi: 10.1080/08820139.2020.1778022. Epub 2020 Jul 02. PMID: 32611246.
Copy Download .nbib Format: NLM
Wharton's Jelly Mesenchymal Stem Cells Exosomes and Conditioned Media Increased Neutrophil Lifespan and Phagocytosis Capacity.

Immunological investigations

Taghavi-Farahabadi M, Mahmoudi M, Rezaei N, Hashemi SM.
PMID: 32777963
Immunol Invest. 2021 Nov;50(8):1042-1057. doi: 10.1080/08820139.2020.1801720. Epub 2020 Aug 11.

Neutrophils are the first cells involved in inflammation and pathogen elimination, but they have a short lifespan. So, strategies for enhancing neutrophil lifespan and activities can be useful in many situations such as patients with immunodeficiencies. Previous researches demonstrated...

Cite
Taghavi-Farahabadi M, Mahmoudi M, Rezaei N, et al. Wharton's Jelly Mesenchymal Stem Cells Exosomes and Conditioned Media Increased Neutrophil Lifespan and Phagocytosis Capacity. Immunol Invest. 2020;50(8):1042-1057doi: 10.1080/08820139.2020.1801720.
Taghavi-Farahabadi, M., Mahmoudi, M., Rezaei, N., & Hashemi, S. M. (2021). Wharton's Jelly Mesenchymal Stem Cells Exosomes and Conditioned Media Increased Neutrophil Lifespan and Phagocytosis Capacity. Immunological investigations, 50(8), 1042-1057. https://doi.org/10.1080/08820139.2020.1801720
Taghavi-Farahabadi, Mahsa, et al. "Wharton's Jelly Mesenchymal Stem Cells Exosomes and Conditioned Media Increased Neutrophil Lifespan and Phagocytosis Capacity." Immunological investigations vol. 50,8 (2021): 1042-1057. doi: https://doi.org/10.1080/08820139.2020.1801720
Taghavi-Farahabadi M, Mahmoudi M, Rezaei N, Hashemi SM. Wharton's Jelly Mesenchymal Stem Cells Exosomes and Conditioned Media Increased Neutrophil Lifespan and Phagocytosis Capacity. Immunol Invest. 2021 Nov;50(8):1042-1057. doi: 10.1080/08820139.2020.1801720. Epub 2020 Aug 11. PMID: 32777963.
Copy Download .nbib Format: NLM
Association of the IL-6 Rs1800796 SNP with Concentration/dose Ratios of Tacrolimus and Donor Liver Function after Transplantation.

Immunological investigations

Wang F, Wei F, Liu H, Wang X, Wang W, Ouyang Y, Liu J, Chen D, Zang Y.
PMID: 32674627
Immunol Invest. 2021 Nov;50(8):939-948. doi: 10.1080/08820139.2020.1793775. Epub 2020 Jul 17.

Interleukin-6 (IL-6) is a proinflammatory cytokine that plays a range of important roles such as in inflammation, immune response, and cell growth regulation. Here, we aimed to assess the potential influence of the IL-6 single nucleotide polymorphism (SNP) rs1800796...

Cite
Wang F, Wei F, Liu H, et al. Association of the IL-6 Rs1800796 SNP with Concentration/dose Ratios of Tacrolimus and Donor Liver Function after Transplantation. Immunol Invest. 2020;50(8):939-948doi: 10.1080/08820139.2020.1793775.
Wang, F., Wei, F., Liu, H., Wang, X., Wang, W., Ouyang, Y., Liu, J., Chen, D., & Zang, Y. (2021). Association of the IL-6 Rs1800796 SNP with Concentration/dose Ratios of Tacrolimus and Donor Liver Function after Transplantation. Immunological investigations, 50(8), 939-948. https://doi.org/10.1080/08820139.2020.1793775
Wang, Feng, et al. "Association of the IL-6 Rs1800796 SNP with Concentration/dose Ratios of Tacrolimus and Donor Liver Function after Transplantation." Immunological investigations vol. 50,8 (2021): 939-948. doi: https://doi.org/10.1080/08820139.2020.1793775
Wang F, Wei F, Liu H, Wang X, Wang W, Ouyang Y, Liu J, Chen D, Zang Y. Association of the IL-6 Rs1800796 SNP with Concentration/dose Ratios of Tacrolimus and Donor Liver Function after Transplantation. Immunol Invest. 2021 Nov;50(8):939-948. doi: 10.1080/08820139.2020.1793775. Epub 2020 Jul 17. PMID: 32674627.
Copy Download .nbib Format: NLM
Letter from the Editor June 2018.

Immunological investigations

Rittenhouse-Olson K.
PMID: 29989507
Immunol Invest. 2018 Aug;47(6):543-546. doi: 10.1080/08820139.2018.1473920.

No abstract available.

Cite
Rittenhouse-Olson K. Letter from the Editor June 2018. Immunol Invest. 2018;47(6):543-546doi: 10.1080/08820139.2018.1473920.
Rittenhouse-Olson, K. (2018). Letter from the Editor June 2018. Immunological investigations, 47(6), 543-546. https://doi.org/10.1080/08820139.2018.1473920
Rittenhouse-Olson, Kate. "Letter from the Editor June 2018." Immunological investigations vol. 47,6 (2018): 543-546. doi: https://doi.org/10.1080/08820139.2018.1473920
Rittenhouse-Olson K. Letter from the Editor June 2018. Immunol Invest. 2018 Aug;47(6):543-546. doi: 10.1080/08820139.2018.1473920. PMID: 29989507.
Copy Download .nbib Format: NLM
Evaluation of Radiation Sensitivity in Patients with Hyper IgM Syndrome.

Immunological investigations

Fekrvand S, Mozdarani H, Delavari S, Sohani M, Nazari F, Kiaee F, Bagheri Y, Azizi G, Hassanpour G, Mozdarani S, Abolhassani H, Aghamohammadi A, Yazdani R.
PMID: 32584193
Immunol Invest. 2021 Jul;50(5):580-596. doi: 10.1080/08820139.2020.1779288. Epub 2020 Jun 25.

BACKGROUND: HIGM syndrome is a rare form of primary immunodeficiencies characterized by normal/increased amounts of serum IgM and decreased serum levels of other switched immunoglobulin classes. Since the affected patients are continuously infected with various types of pathogens and...

Cite
Fekrvand S, Mozdarani H, Delavari S, et al. Evaluation of Radiation Sensitivity in Patients with Hyper IgM Syndrome. Immunol Invest. 2020;50(5):580-596doi: 10.1080/08820139.2020.1779288.
Fekrvand, S., Mozdarani, H., Delavari, S., Sohani, M., Nazari, F., Kiaee, F., Bagheri, Y., Azizi, G., Hassanpour, G., Mozdarani, S., Abolhassani, H., Aghamohammadi, A., & Yazdani, R. (2021). Evaluation of Radiation Sensitivity in Patients with Hyper IgM Syndrome. Immunological investigations, 50(5), 580-596. https://doi.org/10.1080/08820139.2020.1779288
Fekrvand, Saba, et al. "Evaluation of Radiation Sensitivity in Patients with Hyper IgM Syndrome." Immunological investigations vol. 50,5 (2021): 580-596. doi: https://doi.org/10.1080/08820139.2020.1779288
Fekrvand S, Mozdarani H, Delavari S, Sohani M, Nazari F, Kiaee F, Bagheri Y, Azizi G, Hassanpour G, Mozdarani S, Abolhassani H, Aghamohammadi A, Yazdani R. Evaluation of Radiation Sensitivity in Patients with Hyper IgM Syndrome. Immunol Invest. 2021 Jul;50(5):580-596. doi: 10.1080/08820139.2020.1779288. Epub 2020 Jun 25. PMID: 32584193.
Copy Download .nbib Format: NLM
Development of an .

Immunological investigations

Andersen MM, Larsen J, Hansen M, Pedersen AE, Gad M.
PMID: 32573300
Immunol Invest. 2021 Jul;50(5):527-543. doi: 10.1080/08820139.2020.1778024. Epub 2020 Jun 23.

BACKGROUND: Cancer immunotherapies have achieved much success and have become the forefront treatment of cancers previously associated with poor prognosis. However, a major challenge in cancer immunotherapies remains the heterogeneity of the immunoregulatory capacities of cancers, and not all...

Cite
Andersen MM, Larsen J, Hansen M, et al. Development of an . Immunol Invest. 2020;50(5):527-543doi: 10.1080/08820139.2020.1778024.
Andersen, M. M., Larsen, J., Hansen, M., Pedersen, A. E., & Gad, M. (2021). Development of an . Immunological investigations, 50(5), 527-543. https://doi.org/10.1080/08820139.2020.1778024
Andersen, Mikkel Møller, et al. "Development of an ." Immunological investigations vol. 50,5 (2021): 527-543. doi: https://doi.org/10.1080/08820139.2020.1778024
Andersen MM, Larsen J, Hansen M, Pedersen AE, Gad M. Development of an . Immunol Invest. 2021 Jul;50(5):527-543. doi: 10.1080/08820139.2020.1778024. Epub 2020 Jun 23. PMID: 32573300.
Copy Download .nbib Format: NLM
Association of Rs231775 Genetic Variant of Cytotoxic T-lymphocyte Associated Protein 4 with Alopecia Areata Disease in Males: A Case-Control Study.

Immunological investigations

Ismail NA, Toraih EA, Ameen HM, Gomaa AHA, Marie REM.
PMID: 32731768
Immunol Invest. 2021 Nov;50(8):977-986. doi: 10.1080/08820139.2020.1796700. Epub 2020 Jul 30.

BACKGROUND: Alopecia Areata (AA) is a common inflammatory immune-mediated non-scarring hair loss; however, the exact genetic susceptibility remains to be clarified. Cytotoxic T-lymphocyte Associated Protein 4 (CTLA4) has emerged as a central and critically important modulator of immune responses...

Cite
Ismail NA, Toraih EA, Ameen HM, et al. Association of Rs231775 Genetic Variant of Cytotoxic T-lymphocyte Associated Protein 4 with Alopecia Areata Disease in Males: A Case-Control Study. Immunol Invest. 2020;50(8):977-986doi: 10.1080/08820139.2020.1796700.
Ismail, N. A., Toraih, E. A., Ameen, H. M., Gomaa, A. H. A., & Marie, R. E. M. (2021). Association of Rs231775 Genetic Variant of Cytotoxic T-lymphocyte Associated Protein 4 with Alopecia Areata Disease in Males: A Case-Control Study. Immunological investigations, 50(8), 977-986. https://doi.org/10.1080/08820139.2020.1796700
Ismail, Nader Ali, et al. "Association of Rs231775 Genetic Variant of Cytotoxic T-lymphocyte Associated Protein 4 with Alopecia Areata Disease in Males: A Case-Control Study." Immunological investigations vol. 50,8 (2021): 977-986. doi: https://doi.org/10.1080/08820139.2020.1796700
Ismail NA, Toraih EA, Ameen HM, Gomaa AHA, Marie REM. Association of Rs231775 Genetic Variant of Cytotoxic T-lymphocyte Associated Protein 4 with Alopecia Areata Disease in Males: A Case-Control Study. Immunol Invest. 2021 Nov;50(8):977-986. doi: 10.1080/08820139.2020.1796700. Epub 2020 Jul 30. PMID: 32731768.
Copy Download .nbib Format: NLM
MicroRNA-762 Modulates Lipopolysaccharide-induced Acute Lung Injury via SIRT7.

Immunological investigations

Wang C, Chen Y, Cheng NT, Yang ZT, Tang HX, Xu M.
PMID: 34251977
Immunol Invest. 2021 Jul 12;1-16. doi: 10.1080/08820139.2021.1951753. Epub 2021 Jul 12.

No abstract available.

Cite
Wang C, Chen Y, Cheng NT, et al. MicroRNA-762 Modulates Lipopolysaccharide-induced Acute Lung Injury via SIRT7. Immunol Invest. 2021;1-16doi: 10.1080/08820139.2021.1951753.
Wang, C., Chen, Y., Cheng, N. T., Yang, Z. T., Tang, H. X., & Xu, M. (2021). MicroRNA-762 Modulates Lipopolysaccharide-induced Acute Lung Injury via SIRT7. Immunological investigations, 1-16. https://doi.org/10.1080/08820139.2021.1951753
Wang, Cong, et al. "MicroRNA-762 Modulates Lipopolysaccharide-induced Acute Lung Injury via SIRT7." Immunological investigations vol. (2021): 1-16. doi: https://doi.org/10.1080/08820139.2021.1951753
Wang C, Chen Y, Cheng NT, Yang ZT, Tang HX, Xu M. MicroRNA-762 Modulates Lipopolysaccharide-induced Acute Lung Injury via SIRT7. Immunol Invest. 2021 Jul 12;1-16. doi: 10.1080/08820139.2021.1951753. Epub 2021 Jul 12. PMID: 34251977.
Copy Download .nbib Format: NLM
Age-associated Ligand-receptor Interactions Imputed from Nasopharyngeal Transcriptomes of COVID-19 Patients.

Immunological investigations

Batchu S, Yu S.
PMID: 33533266
Immunol Invest. 2021 Feb 03;1-8. doi: 10.1080/08820139.2021.1882484. Epub 2021 Feb 03.

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has exhibited different clinical manifestations amongst various age cohorts. As the immune microenvironment may play a role in clinical progression, it is crucial to examine molecular interactions to gain insight into host...

Cite
Batchu S, Yu S. Age-associated Ligand-receptor Interactions Imputed from Nasopharyngeal Transcriptomes of COVID-19 Patients. Immunol Invest. 2021;1-8doi: 10.1080/08820139.2021.1882484.
Batchu, S., & Yu, S. (2021). Age-associated Ligand-receptor Interactions Imputed from Nasopharyngeal Transcriptomes of COVID-19 Patients. Immunological investigations, 1-8. https://doi.org/10.1080/08820139.2021.1882484
Batchu, Sai, and Yu, Siyuan. "Age-associated Ligand-receptor Interactions Imputed from Nasopharyngeal Transcriptomes of COVID-19 Patients." Immunological investigations vol. (2021): 1-8. doi: https://doi.org/10.1080/08820139.2021.1882484
Batchu S, Yu S. Age-associated Ligand-receptor Interactions Imputed from Nasopharyngeal Transcriptomes of COVID-19 Patients. Immunol Invest. 2021 Feb 03;1-8. doi: 10.1080/08820139.2021.1882484. Epub 2021 Feb 03. PMID: 33533266.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 162 entries